Identifying caregiver-reported modifiable barriers to pediatric oncology clinical trial enrollment and participation

识别照护者报告的儿科肿瘤临床试验入组和参与中可改变的障碍

阅读:1

Abstract

PURPOSE: Clinical trial (ClTr) participation is critical to high-quality pediatric oncology care, but significant sociodemographic disparities in trial enrollment exist. Identifying modifiable barriers to participation such as household material hardship (HMH) and limited health literacy (HL), is essential to improving ClTr access. We compared differences in caregiver-reported barriers to pediatric oncology ClTr participation across socioeconomic status (SES) and racial and ethnic groups through a nationwide anonymous online survey of caregivers of children with cancer. We also explored associations between caregiver HL, HMH, and barriers to trial participation. METHODS: English- and/or Spanish-speaking caregivers of children diagnosed with cancer in the last 5 years completed the Research Participation Survey - Caregiver (RPS-C) to assess barriers to ClTr participation, the validated Health Literacy Survey-12 (HLS(19)-Q12) health literacy assessment, and the WellRx questionnaire measuring HMH. RESULTS: Of 59 participants, 64% were socioeconomically under-resourced, 52.5% identified as racially or ethnically underrepresented, and 62% reported their child had not participated in a ClTr. Under-resourced caregivers reported higher RPS-C barrier scores than adequately resourced caregivers (z=3.18, p=0.001). There were no significant differences in barrier scores across underrepresented vs represented racial and ethnic groups (p=0.203). Lower HL (ρ= 0.557, p<0.001) and higher HMH (ρ = 0.562, p = 0.006) were associated with higher barrier scores. The most frequently identified barrier was difficulty understanding study risks (>90%). CONCLUSIONS: Under-resourced SES, HMH, and lower HL were associated with increased barriers to ClTr participation. Caregivers reported modifiable barriers that could be targets for intervention to improve ClTr participation and reduce disparities in childhood cancer outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。